Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Cash from Investing Activities (2024 - 2025)

Historic Cash from Investing Activities for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to $11.5 million.

  • Pyxis Oncology's Cash from Investing Activities rose 14348750.0% to $11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.3 million, marking a year-over-year change of. This contributed to the annual value of $8.2 million for FY2024, which is 10777.79% up from last year.
  • According to the latest figures from Q3 2025, Pyxis Oncology's Cash from Investing Activities is $11.5 million, which was up 14348750.0% from $15.3 million recorded in Q2 2025.
  • Over the past 5 years, Pyxis Oncology's Cash from Investing Activities peaked at $26.7 million during Q4 2024, and registered a low of -$18.5 million during Q1 2024.